We hope that in the wake of this event, governments will invest more heavily in medical technology, specifically preventive vaccinology and the tools like VPRE that enable its success. Envision a world in which we diligently monitor virus populations in wildlife, livestock, and people. We could predict when, where, and which viruses will cause an outbreak, and have a vaccine ready before it happens.
As we refine our software, we will be able to apply VPRE's framework to all viruses. We will be able to model the evolution of any virus that currently affects humans or has the potential to mutate and begin affecting humans.
As we grow aware of the myriad ways in which our actions impact Earth and everyone on this planet, it is time for humanity to unite with a collective goal: to use our innovation to influence the world positively with our actions. A new world is emerging.
We have worked with various organizations, experts, and locals in order to best formulate the scope of our project, as well as the risks and concerns.
We recognize that our vision may be hard to achieve given the large disparities in socioeconomic status across the world, especially in regards to widespread sequencing of viral genomes and the production and distribution of vaccines. Developing regions may lack funding for the equipment and facilities necessary to support sequencing and independent vaccine development.
Fortunately, the cost of genome sequencing has been declining, making sequencing of widespread sequencing more accessible. Additionally, initiatives such as the 1000 Genomes Project have collected whole genome sequence data at an international level, and give us hope that virus genomes can also be monitored as a global initiative in the future.